Please login to the form below

Not currently logged in
Email:
Password:

tenapanor

This page shows the latest tenapanor news and features for those working in and with pharma, biotech and healthcare.

FDA advisory committee recommends Ardelyx’s Xphozah for chronic kidney disease

FDA advisory committee recommends Ardelyx’s Xphozah for chronic kidney disease

The US Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has recommended Ardelyx’s Xphozah (tenapanor) for the control of serum phosphorus in adult patients with

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...